Prof Tom John
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
376 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
The ‘power of 1’: The ethics and epistemology of ‘N-of-1 trials’ in oncology
DOI: 10.1177/174701612513514012026
Journal article
Treatment and Survival Outcomes for Indigenous and Non-Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross-Sectional Cohort Study
DOI: 10.5694/mja2.702322026
Journal article
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.
DOI: 10.1158/1078-0432.CCR-25-09422026
Journal article
Identifying High-Risk Stage I NSCLC: The Promises and Pitfalls of Tumor-Informed ctDNA
DOI: 10.1016/j.jtho.2026.1037062026
Journal article
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
DOI: 10.1016/j.jtho.2026.1036432026
Journal article
Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality Registry
DOI: 10.1016/j.jtocrr.2026.1009842025
Research grants (ARC, NHMRC, MRFF)
A Registry-Based Randomised Trial of Radiotherapy in Advanced Lung Cancer
RECENT SCHOLARLY WORKS
2026
Journal article
Recent Advances in Combined Medical and Surgical Therapy for Resectable NSCLC
DOI: 10.1002/resp.702382026
Journal article
Treatment Timeliness in Extensive-Stage SCLC and Impact on Survival: A Registry-Based Observational Study
DOI: 10.1016/j.jtocrr.2026.1009782026
Journal article
PP01.56: Final, 6-Year Outcomes with First-Line (1L) Nivolumab Plus Ipilimumab Plus Chemotherapy (N I C) in Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC) from CheckMate 9LA
DOI: 10.1016/j.jtho.2026.1037992026
Journal article
Abstract LB105: Translational analyses from the randomized phase 3 DREAM3R trial: DuRvalumab with chEmotherapy as first line treAtment in advanced pleural Mesothelioma
DOI: 10.1158/1538-7445.am2026-lb105